E Fund Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

E Fund Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,772	Closed	-$88K	–	355
2022 Q1	$88K	Buy	1,772 +878	+98%	+$43.4K	﹤0.01%	319
2021 Q4	$63K	Buy	894 +32	+4%	+$2.7K	﹤0.01%	294
2021 Q3	$80K	Buy	+862	New	+$81.9K	﹤0.01%	263
2021 Q1	$134K	Buy	+1,431	New	+$145K	0.01%	228

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

E Fund Management's VBIV Position: Q2 2022 in Review

E Fund Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2022, closing a stake of 1,772 shares — an estimated $88K sold.

E Fund Management first reported a position in VBIV in Q1 2021 and held it in 4 quarters. The position peaked at $134K in Q1 2021. 130 funds tracked by Wall St. Rank hold VBIV as of Q2 2022.

E Fund Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2022 after selling out during the quarter.
E Fund Management sold 1,772 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2022, an estimated $88K.
E Fund Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2021 and held it in 4 quarters.
E Fund Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $134K in Q1 2021.
130 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2022.

Based on E Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.